Empreendimentos Pague Menos S.A.

R$ 3.97Last Updated 03.11.2025

Issuer Rating

4/7

Performance

Favourable

Risk

Moderate

Recommendation

Hold

Market Cap

R$ 460.87M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
R$ 3.97
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Empreendimentos Pague Menos S.A. operates a chain of pharmacies in Brazil. The company offers medicines and health care products in the areas of contraceptive, gastrointestinal and hepatic, allergy, anti-smoking, erectile dysfunction, ophthalmic, intestinal reeducator, pain, fever, inflammation, weight loss, natural soothing, cholesterol and triglyceride, circulation care, dermatological, diabetes, phytotherapies and natural, cold and flu, vitamin...

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'che

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of PGMN3.SA is 4.7 and suggests 22% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks